This webinar held jointly by BAPM and NPPG (National Neonatal and Paediatric Pharmacy Group) outlines the latest developments to improve drug safety in neonates.
- This includes Development of national fixed drug concentration standards and how these can be used in practise currently and in the future;
- Best practise regarding how to safely infuse inotropes and other short-half life drugs (introducing the NPPG/BAPM joint position statement on this issue).
- Practical considerations for managing these infusions safely eg. during kangaroo care, or acute procedures.
- The role of the network pharmacist in improving drug safety – now and the future.
Programme
- Welcome and Introduction - Eleri Adams
- GIRFT report background Improving drug infusion safety - fixed concentration drugs and plans for the future - Sian Gaze and Steve Tomlin
Safely infusing inotropes and other short-half life drugs - Andrew Wignell
- Introducing the NPPG/BAPM joint position statementSafely infusing inotropes and other short half-life drugs - Natalie Anders and Rebecca Hinton
- Practical considerationsWhat is the role of a network pharmacist? - Nigel Gooding
Q&A - All
Preliminary programme, subject to change
Tickets
Please register in advance.
Date: 18 November 2024
Time: 13:00 - 14:30
Location: Online - Teams webinar
This free webinar is for BAPM Members - please log in to book a ticket. If you're not yet a member of BAPM, you can join here.
Joining the webinar
Shortly after booking you will receive a confirmation email. To add this webinar to your calendar please accept the ICS calendar file attached to this email. Accepting this invite will block out time in your calendar and will include the link to join. (The calendar file can prompt a security warning as it contains the link).
Please note that previous BAPM webinars were sent out as calendar invites but our new process means you must download the calendar file manually if you wish to add this to your calendar.
We will send a reminder with the joining link before the webinar. If you have any questions or experience any issues, please let us know by emailing [email protected].